FrontWell Solutions’ Post

How can we digitally evolve our pharmaceutical industrial sites to incorporate #industry50 solutions and be prepared for level 5 of digital maturity according to BioPhorum Today in Life Sciences 4.0: The next Generation Manufacturing Summit in Barcelona from TBM Group we have flown over the #challenges and #goals of the current pharma industrial sites in bird's view, and we have seen 4 tips that can facilitate this evolution. It has been a pleasure to expose and above all, to learn with you. #digitaltransformation #culturaltransformation #humanleadership #industry50

GMP Pros' Grant Wallace, Justin Tome, and Matthew Deffenbaugh attended the Pharma MES USA 2024 Conference in San Diego last week. Pharma MES 2024 is the only US event on MES in Pharma and Biotech manufacturing. Our goal was to connect with other manufacturing execution systems implementers and industry leaders to trade best practices and discuss how MES plays an essential role in achieving sustainable competitive advantages in the life science industry today. As market pressures push the pharmaceutical industry to improve product quality, reduce costs, and improve efficiencies, Manufacturing Execution Systems (MES) enable pharmaceutical & biotech manufacturers to respond by providing the layer for direct execution of production orders so that they can react dynamically to changing situations in orders, machine states, quality checks and more. In addition, they provide valuable real-time information on requirement changes. And they are an important prerequisite for digitization and Pharma 4.0. #PharmaMESUSA #DigitalTransformation #Pharma #MES

GMP Pros' Grant Wallace, Justin Tome, and Matthew Deffenbaugh attended Pharma MES 2024 in San Diego last week. Pharma MES 2024 is the only US event on MES in Pharma and Biotech manufacturing. Our goal was to connect with other manufacturing execution systems implementers and industry leaders to trade best practices and discuss how MES plays an essential role in achieving sustainable competitive advantages in the life science industry today. As market pressures push the pharmaceutical industry to improve product quality, reduce costs, and improve efficiencies, Manufacturing Execution Systems (MES) enable pharmaceutical & biotech manufacturers to respond by providing the layer for direct execution of production orders so that they can react dynamically to changing situations in orders, machine states, quality checks and more. In addition, they provide valuable real-time information on requirement changes. And they are an important prerequisite for digitization and Pharma 4.0. #PharmaMESUSA #DigitalTransformation #Pharma #MES

📢 Webinar - SaniSure 에서 당신을 기다립니다. [Mixed4Sure™ Bottom Mount - designed specifically for formulation applications] 제형화 단계에서 소용량 교반 성능에 탁월한 혁신적인 솔루션, Mixed4Sure Bottom Mount 을 만나보실 수 있습니다. 📆일정: 6월 26일(수) 오후 6시 - 7시 (한국시간) 🎤강사: Luke Coxon , Global Product Manager for Mixing Technologies  💡주제 During this session: ✔ Explore the features and benefits of the Mixed4Sure™ Bottom Mount. ✔ Learn about its applications and how it enhances efficiency in small-volume mixing. ✔ Engage with and industry expert for insights and perspectives. ✔ Participate in a live technical Q&A session to address your queries directly. 📃참여 대상 Who should attend? Process Engineers, Technical Transfer Specialists, Procurement Specialists, Operations Personnel, Quality Engineers, MSAT, Development Scientists 🔎노하우 공개 This webinar will provide an early preview of performance data in key areas such as: ✔ Shear Forces Analysis ✔ Particulate Generation in Operation USP<788> ✔ Protein Adsorption ✔ Minimum Mixing Volume Characterisation ✔ Fluid Recovery: Last Drop™ Dip Tube 지금 바로 등록 하세요. #Bioprocess #fomulation #DrugSubstance #DrugProduct #MixingInnovation #Webinar #SingleUseSolution #USP788 #Particulate #ShearForce #ProteinAdsorption

Join my colleague Luke Coxon tomorrow for a deep dive insight to one of our key mixing solutions. Register below and see how we can optimize your downstream mixing operations!

🌐 Smart Manufacturing Meets Pharma. Discover how Dell is bridging the gap between operational and information technology to enhance efficiency and reduce costs in pharmaceutical manufacturing. Harnessing the transformative impact of CRISPR and other advances in pharma to accelerate drug discovery with AI-based innovations is just the beginning. Embrace the future of smart manufacturing with us: dell.to/3SNVPYD #SmartManufacturing #PharmaTech #DellSolutions

🌐 Smart Manufacturing Meets Pharma. Discover how Dell is bridging the gap between operational and information technology to enhance efficiency and reduce costs in pharmaceutical manufacturing. Harnessing the transformative impact of CRISPR and other advances in pharma to accelerate drug discovery with AI-based innovations is just the beginning. Embrace the future of smart manufacturing with us: dell.to/3SNVPYD #SmartManufacturing #PharmaTech #DellSolutions

#Single_Use_Assemblies Market Foresees a Substantial Revenue Surge from 2023 to 2032 https://lnkd.in/d-CvmsCy The #global #single-#use #assembly #market is driven by factors such as rising #demand for #biopharmaceuticals, and growing #Research & #Development in biopharmaceutical and life sciences industry. The other key elements that are boosting the market are reduction in cross-contamination by the single-use assembly and faster implementation. Sartorius Stedim Biotech Thermo Fisher Scientific Danaher Corporation GE HealthCare Avantor NewAge Industries, Inc. Parker Hannifin Cole-Parmer Repligen Corporation Entegris Lonza Meissner Charter Medical, LLC CPC - Colder Products Company SaniSure Foxx Life Sciences FlexBiosys, A Repligen Company WHK BioSystems TBL Performance Plastics - A SaniSure Company KEOFITT ROMYNOX #Single_Use_Assemblies #medical_device #business_opportunities #marketanalysis #marketresearch #opportunities #business #future 

How to accelerate product development and commercialization without compromising quality? 🔍 Explore a compelling roundtable article by Pharma's Almanac, where experts discuss innovative approaches to reduce time-to-market without compromising quality. Our Business Development Director, Monica Lazaro, shares insightful perspectives that you don't want to miss. 🚀 Monica's contribution sheds light on 3PBIOVIAN's innovative approaches to drive efficiency and excellence in the biopharmaceutical landscape. 📖 Dive into the discussion! https://lnkd.in/d-_S-6Qs #3PBIOVIAN #Biopharma #CDMO #Biotech #BusinessDevelopment #PharmasAlmanac #IndustryInsights